Novel risk factors for atherosclerosis
- PMID: 10761492
- DOI: 10.4065/75.4.369
Novel risk factors for atherosclerosis
Abstract
In the past several years, evidence has accumulated that factors other than conventional risk factors may contribute to the development of atherosclerosis. Conventional risk factors predict less than one half of future cardiovascular events. Furthermore, conventional risk factors may not have the same causal effect in different ethnic groups in whom novel risk factors may have a role. These newer risk factors for atherosclerosis include homocysteine, fibrinogen, impaired fibrinolysis, increased platelet reactivity, hypercoagulability, lipoprotein(a), small dense low-density lipoprotein cholesterol, and inflammatory-infectious markers. Identification of other markers associated with an increased risk of atherosclerotic vascular disease may allow better insight into the pathobiology of atherosclerosis and facilitate the development of preventive and therapeutic measures. In this review, we discuss the evidence associating these factors in the pathogenesis of atherosclerosis, the mechanism of risk, and the clinical implications of this knowledge.
Comment in
-
Inherited thrombophilia, hypercoagulability, and risk factors for atherosclerosis.Mayo Clin Proc. 2000 Aug;75(8):870-1. doi: 10.4065/75.8.870-a. Mayo Clin Proc. 2000. PMID: 10943248 No abstract available.
Similar articles
-
[Novel risk factors for atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and cholesterol as predictors of peripheral arteriopathy].Ital Heart J Suppl. 2001 Sep;2(9):1031-3. Ital Heart J Suppl. 2001. PMID: 11675827 Italian. No abstract available.
-
Conditional risk factors for atherosclerosis.Mayo Clin Proc. 2005 Feb;80(2):219-30. doi: 10.4065/80.2.219. Mayo Clin Proc. 2005. PMID: 15704777 Review.
-
[Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].MMW Fortschr Med. 2001 Jan 25;143(4):22-4. MMW Fortschr Med. 2001. PMID: 11219276 German.
-
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.JAMA. 2003 Aug 20;290(7):932-40. doi: 10.1001/jama.290.7.932. JAMA. 2003. PMID: 12928471 Review.
-
Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.J Rheumatol. 2002 May;29(5):875-82. J Rheumatol. 2002. PMID: 12022343
Cited by
-
Novel serologic markers of cardiovascular risk.Curr Atheroscler Rep. 2005 Mar;7(2):148-54. doi: 10.1007/s11883-005-0038-9. Curr Atheroscler Rep. 2005. PMID: 15727731 Review.
-
Relationship between fetal-type posterior cerebral artery and basilar artery atherosclerosis.Front Neurol. 2025 Mar 19;16:1533281. doi: 10.3389/fneur.2025.1533281. eCollection 2025. Front Neurol. 2025. PMID: 40212612 Free PMC article.
-
Atherosclerosis and antiphospholipid syndrome.Clin Rev Allergy Immunol. 2003 Aug;25(1):79-88. doi: 10.1385/CRIAI:25:1:79. Clin Rev Allergy Immunol. 2003. PMID: 12794263 Review.
-
The significance of lower extremity peripheral arterial disease.Clin Cardiol. 2002 Jan;25(1):3-10. doi: 10.1002/clc.4950250103. Clin Cardiol. 2002. PMID: 11808837 Free PMC article. Review.
-
Investigating the relationship between opium use and coronary slow flow: a propensity score matched case-control study.BMJ Open. 2024 Dec 11;14(12):e090471. doi: 10.1136/bmjopen-2024-090471. BMJ Open. 2024. PMID: 39663169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous